Leading Kidney Care in Shanghai
The Department of Nephrology at Fudan University's Zhongshan Hospital is one of China's most respected centers for the diagnosis and management of kidney disease. With expertise spanning chronic kidney disease, glomerulonephritis, dialysis, and kidney transplantation, the department provides comprehensive, evidence-based care for patients at every stage of renal disease — from early detection and preservation of kidney function to advanced renal replacement therapy.
For international patients seeking specialist nephrology care in Shanghai, China Medical Concierge Shanghai (CMCS) provides seamless support — from medical record translation and specialist scheduling to on-site accompaniment and long-term follow-up coordination.
About the Department
Zhongshan Hospital's nephrology department is a national key clinical specialty with a long history of clinical excellence and research leadership. The department operates a comprehensive renal unit encompassing inpatient wards, a dedicated dialysis center, a kidney biopsy service, and close integration with the hospital's kidney transplant program.
The dialysis center is one of the largest in Shanghai, offering hemodialysis, peritoneal dialysis, and continuous renal replacement therapy (CRRT) for critically ill patients. The department's renal pathology service provides expert interpretation of kidney biopsies, enabling precise diagnosis of glomerular, tubular, and interstitial diseases that guide targeted treatment decisions.
Faculty members are active contributors to national nephrology guidelines and clinical research, with publications in leading journals including Journal of the American Society of Nephrology (JASN), Kidney International, and Clinical Journal of the American Society of Nephrology (CJASN).
Conditions Treated
- Chronic Kidney Disease (CKD) — Comprehensive management across all stages (CKD 1–5), with a focus on slowing progression and preserving residual function
- IgA Nephropathy — China's most common primary glomerulonephritis, with expertise in risk stratification and targeted therapy including SGLT2 inhibitors and sparsentan
- Membranous Nephropathy — Anti-PLA2R antibody testing, immunosuppressive therapy, and rituximab protocols
- Lupus Nephritis — Multidisciplinary management with rheumatology, including biologic therapies
- Diabetic Kidney Disease — Integrated management with endocrinology for cardiorenal protection
- Hypertensive Nephrosclerosis — Blood pressure optimization and renoprotective therapy
- Nephrotic Syndrome — Minimal change disease, focal segmental glomerulosclerosis (FSGS), and membranoproliferative GN
- Acute Kidney Injury (AKI) — Intensive management including CRRT for critically ill patients
- Polycystic Kidney Disease (PKD) — Tolvaptan therapy and genetic counseling for ADPKD
- Tubulointerstitial Nephritis — Drug-induced, autoimmune, and infectious causes
- Renovascular Disease — Renal artery stenosis and ischemic nephropathy in collaboration with vascular surgery
- End-Stage Kidney Disease (ESKD) — Hemodialysis, peritoneal dialysis, and kidney transplant evaluation and preparation
- Post-Transplant Nephrology — Immunosuppression management, rejection surveillance, and long-term graft care
- Hereditary Kidney Diseases — Alport syndrome, Fabry disease, and other genetic nephropathies
Leading Specialist
Prof. Ding Xiaoqiang (丁小强) — Director, Nephrology
Prof. Ding Xiaoqiang is one of China's most distinguished nephrologists and a nationally recognized authority in chronic kidney disease management, dialysis medicine, and acute kidney injury. As Director of the Department of Nephrology at Zhongshan Hospital, he has led the department's growth into one of China's premier renal centers over more than two decades of clinical and academic leadership.
Prof. Ding is particularly recognized for his contributions to the understanding and management of acute kidney injury (AKI) in critically ill patients, including the development and refinement of continuous renal replacement therapy (CRRT) protocols that have been widely adopted across China. His research on AKI biomarkers, renal recovery, and the long-term consequences of AKI has been published in leading international nephrology journals and has influenced clinical practice guidelines nationally.
In chronic kidney disease, Prof. Ding has been a strong advocate for early intervention and integrated cardiorenal management, recognizing the close relationship between kidney disease and cardiovascular risk. He has extensive experience in the management of complex glomerulonephritis, including IgA nephropathy, membranous nephropathy, and lupus nephritis, and has been involved in multiple national and international clinical trials evaluating novel therapies for these conditions.
Prof. Ding is a past president of the Chinese Society of Nephrology and serves on the editorial boards of several international nephrology journals. He is a frequent invited speaker at major nephrology congresses including ERA, ASN, and ISN, and has trained numerous nephrologists across China and internationally.
Diagnostic & Treatment Capabilities
Diagnostic Services
- Kidney Biopsy — Ultrasound-guided percutaneous renal biopsy with expert pathological interpretation including light microscopy, immunofluorescence, and electron microscopy
- Renal Pathology — Dedicated renal pathology service for precise glomerular, tubular, and vascular disease classification
- Biomarker Testing — Anti-PLA2R, ANCA, anti-GBM, complement panels, and genetic testing for hereditary nephropathies
- Renal Function Assessment — GFR measurement, proteinuria quantification, and tubular function testing
- Renal Imaging — Ultrasound, CT, MRI, and nuclear medicine renal scans for structural and functional assessment
Renal Replacement Therapy
- Hemodialysis — Conventional and high-flux hemodialysis, hemodiafiltration (HDF), and online HDF for optimal solute clearance
- Peritoneal Dialysis — CAPD and APD (automated peritoneal dialysis) with a dedicated PD nurse team and remote monitoring
- Continuous Renal Replacement Therapy (CRRT) — CVVH, CVVHD, and CVVHDF for critically ill patients with AKI in the ICU
- Therapeutic Apheresis — Plasmapheresis and immunoadsorption for antibody-mediated kidney diseases
Medical Management
- Immunosuppressive Therapy — Corticosteroids, mycophenolate, tacrolimus, cyclosporine, and rituximab for immune-mediated glomerulonephritis
- Novel Targeted Therapies — SGLT2 inhibitors, endothelin receptor antagonists, and complement inhibitors for CKD progression
- Cardiorenal Syndrome Management — Integrated treatment of concurrent heart and kidney failure
- CKD-Mineral Bone Disorder (CKD-MBD) — Management of secondary hyperparathyroidism, renal osteodystrophy, and vascular calcification
Why International Patients Choose Zhongshan Nephrology
- National Leadership — One of China's premier nephrology centers, led by a past president of the Chinese Society of Nephrology
- Expert Renal Pathology — Precise kidney biopsy interpretation enabling targeted, diagnosis-specific treatment
- Comprehensive Dialysis Program — Full range of renal replacement modalities including advanced HDF and CRRT
- Access to Novel Therapies — Participation in clinical trials providing access to cutting-edge treatments for IgA nephropathy, membranous nephropathy, and other conditions
- Integrated Multidisciplinary Care — Close collaboration with cardiology, endocrinology, rheumatology, and transplant surgery
- Cost-Effectiveness — World-class nephrology care at significantly lower cost than equivalent treatment in Western countries
The CMCS Patient Journey
- Initial Inquiry — Share your kidney disease history, recent lab results (creatinine, GFR, proteinuria), biopsy reports, and imaging with CMCS.
- Medical Record Preparation — We translate and organize your records for specialist pre-consultation review.
- Specialist Matching — We identify the most appropriate nephrologist based on your specific condition and treatment needs.
- Priority Scheduling — We secure a consultation with minimal waiting time, including urgent slots for rapidly progressive kidney disease.
- Travel & Logistics — Assistance with visa invitation letters, accommodation near Zhongshan Hospital, and Shanghai airport transfers.
- On-Site Concierge — Bilingual coordinators accompany you throughout your hospital visits, managing registration, translation, and communication with your nephrology team.
- Procedure & Admission Support — Full coordination of kidney biopsy, dialysis initiation, or inpatient admission as required.
- Post-Treatment Follow-Up — Lab result translation, biopsy report interpretation, and remote follow-up coordination after you return home.
Book a Consultation
If you are seeking expert nephrology care in Shanghai — whether for a second opinion on kidney disease, advanced dialysis, or evaluation for kidney transplantation — CMCS can arrange a specialist consultation with Zhongshan Hospital's nephrology team.
📧 contract@medicalsh.com
💬 WhatsApp: https://wa.me/message/3AM6KAGCW2BAD1
🌐 www.medicalsh.com
0 commentaire